Regulation of mast cell growth and proliferation

Critical Reviews in Oncology/Hematology

Volumn 23, Issue 2, 1996, Pages 131-150

  Nechushtan, Hovav ^a   Razin, Ehud ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; GROWTH FACTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

APOPTOSIS; CANCER; CELL GROWTH; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN CELL; MAST CELL; NONHUMAN; REVIEW;

EID: 0030176084     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/1040-8428(96)00200-4     Document Type: Review

References (132)

1. [1] Galli SJ. New concepts about the mast cell. N Engl J Med 328:257-256, 1993.
2. [2] Galli SJ, Gordon JR, Wershil BK. Mast cells in allergy in inflamation. Agents Actions Suppl 43:209-220, 1993.
3. [3] Galli SJ, Austen KF. Mast cell and basophil differentiation in health and disease. New York: Raven Press, 1989.
4. [4] Kitamura Y, Kasugai T, Arizono N, Matsuda H. Development of mast cells and basophils: processes and regulation mechanisms. Am J Med Sci 306: 185-191, 1993.
5. [5] Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 7: 59-76, 1989.
6. [6] Galli SJ, Tsai M, Gordon JR, Geissler EN, Wershil BK. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or S1/MGF (SCF) loci. Ann NY Acad Sci 664: 69-88, 1992.
7. [7] Wershil BK, Theodos CM, Galli SJ, Titus RG. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 152: 4563-4571, 1994.
8. [8] Abe TY, Sugaya H, Ishida K, Khan WI, Tadsemir I, Yoshimura KJ. Intestinal protection against Strongyloides ratti and mastocytosis induced by adminstration of IL-3 in mice. Immunology 80: 116-121, 1993.
9. [9] Bashkin P, Razin E, Eldor A, Vlodavsky I. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 75: 2204-2412, 1990.
10. [10] Toi M, Harris AL, Bicknell R, Interleukin-4 is a potent mitogen for capillary endothelium. Biochem Biophys Res Commun 174: 1287-1293, 1991.
11. [11] Toi M, Bicknell R, Harris AL. Inhibition of colon and breast carcinoma cell growth by IL-4. Cancer Res 52: 275-280, 1992.
12. [12] Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-α)/cachectin by mouse mast cells stimulated via the Fc∈RI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 174: 103-107, 1991.
13. [13] Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B. Prognostic significance of cosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol 20: 159-163, 1989.
14. [14] Fisher ER, Sass R, Watkins G, Johal J, Fisher B. Tissue mast cells in breast cancer. Breast Cancer Res Treat 5: 285-291, 1985.
15. [15] Aaltomaa S, Lipponen P, Papinaho S, Kosma VM. Mast cells in breast cancer. Anticancer Res 13: 785-788, 1993.
16. [16] Dabbous MK, Haney L, Nicolson GL, Eckley D, Woolley DE. Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma. Br J Cancer 163: 873-878, 1991.
17. [17] Benyon EY, Bissonnette D, Befus AD. Intestinal mast cells in inflammatory bowel disease: Pathogenesis and therapeutic implications. In: MacDermott RP, Stenson WF. eds. Inflammatory Bowel Disease. New York: Elsevier, 1992: 189-199.
18. [18] Dvorak AM, McLeod RS, Onderdonk A et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol 99: 74-83, 1992.
19. [19] Fox CC, Moore WC, Lichtenstein LM. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci 36: 179-184, 1991.
20. [20] Sant GR, Theoharides TC. The role of the mast cell in interstitial cystitis. Urol Clin North Am 21: 41-53, 1994.
21. [21] el-Mansoury M, Boucher W, Sant GR, Theoharides TC. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol 152: 350-353, 1994.
22. [22] Patra PB, Westfall DP. Potentiation of purinergic neurotransmission in guinea pig urinary bladder by histamine. J Urol 151: 787-790, 1994.
23. [23] Asha P, Nair K, Hahn S, Banholzer R, Hirsch HH, Moroni C. Cyclosporin A inhibits growth of autocrine tumor cell lines by destabilizing interleukin-3 mRNA. Nature 369: 239-244, 1994.
24. [24] Friery M. Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 69: 385-392, 1992.
25. [25] Seibold JR, Giorno RC, Claman HN. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheumat 33: 1702-1709, 1990.
26. [26] Chanez P, Lacoste YJ, Guillot B et al. Mast cell contribution to the fibrosing alveolitis of the lung. Am Rev Res Dis 147: 1497-1502, 1993.
27. [27] Pesci A, Bertorelli G, Gabrielli M, Olivieri D. Mast cells in fibrotic lung disorders. Chest 103: 989-996, 1993.
28. [28] Sanguinetti C, Greco F, De-Palma L, Specchia N, Toesca A, Nori S. The ultrastructure of peripheral neurofibroma: the role of mast cells and their interaction with perineurial cells. Ital J Orthop Traumatol 18: 207-216, 1992.
29. [29] Nurnberger M, Moll I. Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 5. Dermatology 188: 296-269, 1994.
30. [30] Hirota S, Nomura S, Asada H, Ito A, Morii E, Kitamura Y. Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues. Arch Pathol Lab Med 117: 996-999, 1993.
31. [31] Ryan JJ, Klein KA, Neuberger TJ et al. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neurosci Res 37: 415-432, 1994.
32. [32] Riccardi VM. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 129: 577-581, 1993.
33. [33] Rothe MJ, Nowak M, Kerdel FA. The mast cell in health and disease. J Am Acad Dermatol 23: 615-624, 1990.
34. [34] Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96: 2S-4S, 1991.
35. [35] Horny HP, Schumacher U, McCullagh P, Wehrmann M, Roche WR, Kaiserling E. Proliferation of reactive and neoplastic human tissue mast cells. An immunohistochemical study using the antibody PC10 (anti-PCNA). J Pathol 170: 265-270, 1993.
36. [36] Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. J Invest Dermatol 96: 15S-18S, 1991.
37. [37] Metcalfe DD. The treatment of mastocytosis: an overview. J Invest Dermatol 96: 55S-56S, 1991.
38. [38] Kluin-Nelemans HC, Jansen JH, Breukelman H et al. Response to interferon α-2b in a patient with systemic mastocytosis. N Engl J Med 326: 619-623, 1992.
39. [39] Katz HR, Kaye RE, Austen KF. Mast cell biochemical and functional heterogeneity. Transplant Proc 23: 2900-2904, 1991.
40. [40] Ginsburg H, Sachs L. Formation of pure suspension of mast cells fromtissue culture by differentiation of lympoid cells from the mouse thymud. J Natl Canc Inst 31: 1-39, 1963.
41. [41] Hasthorpe S. A hemopoietic cell line dependent upon a factor in pokeweed mitogen-stimulated spleen cell conditioning medium. J Cell Physiol 105: 379-384, 1980.
42. [42] Schrader JW, Lewis SJ, Clark-Lewis I, Culvenor JG. The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci USA 78: 323-327, 1981.
43. [43] Nabel G, Galli SJ, Dvorak AM, Dvorak HF, Cantor H. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature 291: 332-334, 1981.
44. [44] Razin E, Cordon-Cardo C, Good RA. Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci USA 78: 2559-2561, 1981.
45. [45] Tertian G, Yung YP, Guy-Grand D, Moore MA, Long-term in-vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique. J Immunol 127: 788-794, 1981.
46. [46] Nagao K, Yokoro K, Aaronson SA. Continuous lines of basophil/mast cells derived from normal mouse bone marrow. Science 212: 333-335, 1981.
47. [47] Ihle JN, Keller J, Oroszlan S et al. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol 131: 282-287, 1983.
48. [48] Smith CA, Rennick DM. Characterization of a murine lymphokine distinct from IL-2 and IL-3 possesing a T cell growth fact or activity and a mast cell growth activity that synergizes with IL-3. Proc Natl Acad Sci USA 83: 1857-1861, 1983.
49. [49] Boulay JL, Paul WE. The interleukin-4 family of lymphokines. Curr Opin Immunol 4: 294-298, 1992.
50. [50] Razin E, Ihle JN, Seldin D et al. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 132: 1479-1486, 1984.
51. [51] Saito H, Hatake K, Dvorak AM et al. Selective differentiation and proliferatiom of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci USA 85: 2288-2292, 1988.
52. [52] Valent P, Besemer J, Sillaber C et al. Failure to detect IL-3 binding sites on human mast cells. J Immunol 145: 3432-3437, 1990.
53. [53] Nilsson G, Blom T, Kusche-Gulberg M et al. Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 39: 489-498, 1994.
54. [54] Hida T, Ueda R, Sekido Y et al. Ectopic expression of c-kit in small-cell lung cancer. Int J Cancer Suppl 8: 108-109, 1994.
55. [55] Gilead L, Bibi O, Razin E. Fibroblasts induce heparin synthesis in chondroitin sulfate E containing human bone marrow-derived mast cells. Blood 76: 1188-1195, 1990.
56. [56] Kirshenbaum AS, Goff JP, Dreskin SC, Irani AM, Schwartz LB, Metcalfe DD. IL-3-dependent growth of basophil-like cells and mast like cells from human bone marrow. J Immunol 142: 2424-2429, 1989.
57. [57] Reynolds DS, Stevens RL, Lane WS, Carr MH, Austen KF, Serafin WE. Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases. Proc Natl Acad Sci USA 87: 3230-32344, 1990.
58. [58] Serafin WE, Sullivan TP, Conder GA et al. Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat. J Biol Chem 266: 1934-1941, 1992.
59. [59] Eklund KK, Ghildyal N, Austen KF, Stevens RL. Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. J Immunol 151: 4266-4273, 1993.
60. [60] Ghildyal N, Friend DS, Nicodemus CF, Austen KF, Stevens RL. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol 151: 3206-3214, 1993.
61. [61] Urban JF Jr, Katona IM, Paul WE, Finkelman FD. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc Natl Acad Sci USA 88: 5513-5517, 1991.
62. [62] Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol 147: 1387-1391, 1991.
63. [63] Volk-Platzer B, Valent P, Radaszkievicz T, Mayer P, Bettelheim P, Wolf K. Recombinant human IL-3 induces proliferation of inflammatory cells and keratinocytes in vivo. Lab Invest 64: 557-566, 1991.
64. [64] Kitamura Y, Go S. Decreased production of mast cells in S1/S1d anemic mice. Blood 53: 492-497, 1979.
65. [65] Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452, 1978.
66. [66] Yarden Y, Kuang WJ, Yang-Feng et al. A human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341-3351, 1987.
67. [67] Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185-192, 1988.
68. [68] Galli SJ, Zsebo KM. Geissler EN. The kit ligand, stem cell factor. Adv Immunol 55: 1-96, 1994.
69. [69] Tsujimura T, Furitsu T, Morimoto M et al. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83: 2619-2626, 1994.
70. [70] Kanakura Y, Furitsu T, Tsujimura T et al. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line. Leukemia 8 Suppl 1: S18-S22, 1994.
71. [71] Mitsui H, Furitsu T, Dvorak AM et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90: 735-739, 1993.
72. [72] Irani AM, Nilsson G, Miettinen U et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80: 3009-3021, 1992.
73. [73] Longley BJ Jr, Morganroth GS, Tyrrell et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328: 1302-1307, 1993.
74. [74] Valent P. The riddle of the mast cell: c-kit ligand as the missing link? Immunol Today 15: 111-114, 1994.
75. [75] Eklund KK, Ghildyal N, Austen KF, Friend DS, Schiller V, Stevens RL. Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in-vivo express the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates. J Exp Med 180: 67-73, 1994.
76. [76] Arizono N, Kasugai T, Yamada M et al. Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats. Blood 81: 2572-2578, 1993.
77. [77] Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 133: 358-366, 1977.
78. [78] Matsuda H, Kannan Y, Ushio H et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 174: 7-14, 1991.
79. [79] Leon A, Buriani A, Dal-toso R, Fabris M, Romanello S, ALoe L, Levi-Montalcini R. Mast cells synthesize store and release nerve growth factor. Proc Natl Acad Sci USA 891: 3739-3743, 1994.
80. [80] Tuveri MA, Passiu G, Mathieu A, Aloe L. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin Exp Rheumatol 11: 319-322, 1993.
81. [81] Horigome K, Bullock ED, Johnson EM Jr. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 269: 2695-2702, 1994.
82. [82] Aloe L. The effect of nerve growth factor and its antibody on mast cells in vivo. J Neuroimmunol 18: 1-12, 1988.
83. [83] Stauber WT. Fritz VK, Burskovaskaya TE, Ilyina-Kakueva EI. Effect of injury on mast cells of rat gastocnemius muscle with respect to gravitational exposure. Exp Mol Pathol 59: 87-94. 1993.
84. [84] Olivetti G, Lagrasta C, Ricci R, Sonnenblick EH, Capasso JM, Anversa P. Long-term pressure-induced cardiac hypertrophy: capillary and mast cell proliferation. Am J Physiol 257 (6 Pt 2): H1766-H1772, 1989.
85. [85] Osinski MA, Dahl JL, Bass P. Proliferation of mast cells in the smooth muscle of denervated rat jejunum. J Autonmic Nerv Syst 45 (2): 164-174, 1993.
86. [86] Stead RM, Dixon MF, Bramwell NH, Riddel RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97: 575-585, 1989.
87. [87] Dastych J, Metcalfe DD. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152: 213-219, 1994.
88. [88] Thompson HL, Thomas L, Metcalfe DD. Murine mast cells attach to and migrate on laminin, fibronectin, and matrigel-coated surfaces in response to Fc epsilon RI-mediated signals. Clin Exp Allergy 23: 270-275, 1993.
89. [89] Bianchine PJ, Burd PR, Metcalfe DD. IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol 149: 3665-3671, 1992.
90. [90] Nafziger J, Arock M, Guillosson JJ, Wietzerbin J. Specific high-affinity receptors for interferon-γ on mouse bone marrow-derived mast cells: inhibitory effect of interferon-γ on mast cell precursors. Eur J Immunol 20: 113-117, 1990.
91. [91] Takagi M, Koike K, Nakahata T. Antiproliferative effect of IFN-γ on proliferation of mouse connective tissue-type mast cells. J Immunol 145: 1880-1884, 1990.
92. [92] Tchekneva E, Serafin WE. Kirsten sarcoma virus-immortalized mast cell lines. Reversible inhibition of growth by dexamethasone and evidence for the presence of an autocrine growth factor. J Immunol 152: 5912-5921, 1994.
93. [93] Mekori YA, Metcalfe DD. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol 153: 2194-2120, 1994.
94. [94] Curtis GH, Patrick MK, Catto-Smith AG, Gall DG. Intestinal anaphylaxis in the rat. Effect of chronic antigen exposure. Gastroenterology 98: 1558-1566, 1990.
95. [95] Takagi M, Nakahata T, Koike K et al. Stimulation of connective tissue-type mast cell proliferation by crosslinking of cell-bound IgE. J Exp Med 170: 233-244, 1989.
96. [96] Baranes D, Razin E. PKC regulates proliferation of mast cells and the expression of Fos and Jun proto-oncogene mRNAs during activation by IgE-Ag or calcium ionophore A23187. Blood 78: 2354-2366, 1991.
97. [97] Baranes D, Lewin I, Razin E. Serum modulates mast cell response to IgE-Ag stimulation. Eur J Immunol 23: 291-294, 1992.
98. [98] Tsai M, Tam SY, Galli SJ. Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3. or IgE and antigen. Eur J Immunol 23: 867-872, 1993.
99. [99] Sillaber C, Strobl H, Bevec D et al. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 147: 4224-4228, 1991.
100. [100] Welham MJ, Schrader JW. Modulation of c-kit mRNA and protein by hemopoietic growth factors. Mol Cell Biol 11: 2901-2904, 1991.
101. + cells. Adv Immunol 53: 1-35, 1993.
102. [102] Keegan AD, Pierce JH, Artrip J, Plaut M, Paul WE. Ligand stimulation of transfected and endogenous growth factor receptors enhances cytokine production by mast cells. EMBO J 10: 3675-3682, 1991.
103. [103] Chaikin E, Ziltener H, Razin E. Protein Kinase C plays an inhibitory role in IL-3 and IL-4 mediated mast cell proliferation. J Biol Chem 265: 22109-22116, 1990.
104. [104] Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today 10: 381-386, 1989.
105. [105] Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88: 493-499, 1991.
106. [106] Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152: 3606-3614, 1994.
107. [107] Frandji P, Oskeritzian C, Cacaraci F et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151: 6318-6328, 1993.
108. [108] Gauchat JF, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365: 340-343, 1993.
109. [109] Rodriguez-Tarduchy G, Collins MKL, Garcia I, Lopez Rivas A. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 149: 535-540, 1992.
110. [110] Mekori YA, Oh CK, Metcalfe DD. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by 1993 c-kit ligand. J Immunol 151: 3775-3784, 1993.
111. [111] Yee NS, Paek I, Besmer P. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med 179: 1777-1787, 1994.
112. [112] Pierce JH, Di-Fiore PP, Aaronson et al. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41: 685-693, 1985.
113. [113] Welham MJ, Schrader JW. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways. J Immunol 149: 2772-2783, 1992.
114. [114] Welham MJ, Duronio V, Schrader JW. Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. J Biol Chem 269: 5865-5873, 1994.
115. [115] Shearman MS, Herbst R, Schlessinger J, Ullrich A. Phosphatidylinositol 3'-kinase associates with p145 c-kit as part of a cell type characteristic multimeric signalling complex. EMBO J 12: 3817-3826, 1993.
116. [116] Tsai M, Chen RH, Tam SY, Blenis J, Galli SJ. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc∈RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur J Immunol 23: 3286-3291, 1993.
117. [117] Beaven MA, Metzger H. Signal transduction by the Fc receptors: the Fc∈RI case. Immunol Today 14: 222-226, 1993.
118. [118] Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991.
119. [119] Chaikin E, Hakeem I, Razin E. Enhancement of interleukin-3-dependent mast cell proliferation by supression of c-jun expression. J Biol Chem 269: 8498-8503, 1994.
120. [120] Chaikin E, Hakeem I, Razin E. The incapability of IL-4 to induce AP-1 activity in murine mast cells. Int Arch Allergy Immunol 1995. In press.
121. [121] Lewin I, Nechushtan H, Qingen K, Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood 82: 3745-3751, 1993.
122. [122] Lewin I, Jacob-Hirsch J, Zang ZC, Kupershtein V, Szallasi Z, Rivera J, Razin E. Aggregation of the Fc∈RI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding activity: the dependency on PKC-β. J Biol Chem 271: 1514-1519, 1996.
123. 2+ and purified isozymes in washed permeabilized cells. J Biol Chem 268: 1749-1756, 1993.
124. [124] Razin E, Szallasi Z, Kazanietz M, Blumberg PM, Rivera J. Protein kinase C-β and ∈ link the mast cell high affinity receptor for IgE to the expression of fos and jun. Proc Natl Acad Sci USA 91: 7722-7726, 1994.
125. [125] Hodgkinson CA, Moore KJ, Nakayama A et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74: 395-404, 1993.
126. [126] Ebi Y, Kasugai T, Seino Y, Onoue H, Kanemoto T, Kitamura Y. Mechanism of mast cell deficiency in mutant mice of mi/mi genotype: an analysis by co-culture of mast cells and fibroblasts. Blood 75: 1247-1251, 1990.
127. [127] Dubreil P, Forrrester L, Rottapel R, Reedy KM, Fujita J, Bernstein A. The c-fms gene complements the mitogen defect in mast cells deerived from mutant W mice but not mi (microphthalmia) mice. Proc Natl Acad Sci USA 88: 2342-2345, 1991.
128. [128] Jippo-Kanemoto T, Adachi S, Ebi Y et al. BALB/3T3 fibroblast-conditioned medium attracts cultured mast cells derived from W/W but not from mi/mi mutant mice, both of which are deficient in mast cells. Blood 80: 1933-1941, 1992.
129. [129] Hughes MJ, Lingrel JB, Krakowsky JM, Anderson KP. A helix-loop-helix transcription factor-like gene is located at the mi locus. J Biol Chem 268: 20687-20690, 1993.
130. [130] Varmus HE, Lowell CA. Cancer genes and hematopoiesis. Blood 83: 5-9, 1994.
131. [131] Domen J, van-der-Lugt NM, Laird PW et al. Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells Blood 82: 1445-1452, 1993.
132. [132] Dombrowicz D, Flamand V, Brigman KK, Koller BH, Kinet JP. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 75: 969-976, 1993.